PPARA and colorectal carcinoma: In this regard, a study performed by Takano et al. demonstrated that pioglitazone, a PPAR-ɣ antagonist, inhibits CRC liver metastasis via downregulation of COX-2 and cyclin D1 expression on HT-29 and SW480 colon cancer cell lines (Table 2) [131].